New cancer drug begins first human tests
NCT ID NCT03833700
Summary
This is an early-stage study testing a new drug called E7386 in people with advanced solid tumors that have spread or returned after previous treatments. The main goal is to find the safest dose and understand side effects in about 70 participants. Researchers will also check if the drug shows any signs of helping control cancer growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Eisai Trial Site #1
Chuo Ku, Tokyo, Japan
-
Eisai Trial Site #2
Kashiwa, Chiba, Japan
-
Eisai Trial Site #3
Nagaizumi-cho, Shizuoka, Japan
-
Eisai Trial Site #4
Fukuoka, Japan
-
Eisai Trial Site #5
Sapporo, Hokkaido, Japan
-
Eisai Trial Site#6
Osaka, Japan
-
Eisai Trial Site#7
Nagoya, Aichi-ken, Japan
-
Eisai Trial Site#8
Sendai, Miyagi, Japan
Conditions
Explore the condition pages connected to this study.